The U.S. Food and Drug Administration warned two companies to stop illegally marketing CBD products with claims that it can treat opioid addiction and other medical conditions.
The warning letters were sent Thursday to:
- BIOTA Biosciences, LLC, of Washington state
- Homero Corp., doing business as Nature’s CBD Oil Distribution of New Hampshire
The FDA accuses both companies of marketing and distributing CBD products for serious diseases and as an alternative to opioids.
The letters give the companies 15 days to demonstrate how they’ll correct the violations.
To read more about marketing CBD without running afoul of the FDA, click here.